VIPERLAX IV Powder and Solvent for Preparing Injection
Solution
Composition:
Macrovipera lebetina ≥ 500 LD50 NU/Vial
Vipera ammodytes ≥ 1000 LD50 NU/Vial
Montivipera xanthina ≥ 500 LD50 NU/Vial snake venom immunoglobulin F(ab')2 fragments (equine origin). Each ml contains a maximum of 100 mg of protein (< 100 mg/ml).
Indication:
This pharmaceutical product is a polyvalent purified snake venom antiserum indicated for the treatment of poisonings caused by the bites of Macrovipera lebetina (Great Viper), Vipera ammodytes (Horned Viper) and Montivipera xanthina (Striped Viper) snakes of the Viperidae family.
Dosage and application:
VIPERLAX is administered by intravenous injection after diluting with10 ml of 0.9% saline in the box. The most important rule to be followed when applying antiserum against snake bite is to take the antiserum as soon as possible and to prevent the snake venom from entering the bloodstream. The starting dose of the immunoserum is not according to body mass; It is given according to the severity of symptoms and the need for additional doses is dependent on clinical response.
Packing:
1 vial + 10 ml 0.9 % NaCl isotonic solution
Storage:
ViperLAX is a lyophilized product, stable for 2 years at 25C and 6 months at 40C.